This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Allscripts Professional EHR™ 13.0 Is Generally Available

CHICAGO, Sept. 3, 2013 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) announced today that Allscripts Professional™ Electronic Health Record (EHR) 13.0 is now generally available. The release of Allscripts Professional EHR 13.0 is part of the company's ongoing client commitment to provide the tools needed to help them achieve Meaningful Use Stages 1 and 2. 

"Allscripts Professional EHR 13.0 is a reflection of our unwavering commitment to our clients," said Paul M. Black, President and Chief Executive Officer of Allscripts. "This new version of Professional is a more powerful and more complete solution, with exceptional function and features."

Allscripts Professional EHR 13.0 was certified for meeting ONC 2014 Edition Standards & Certification Criteria set by the Certification Commission for Health Information Technology (CCHIT®). ONC 2014 certification supports both Stage 1 and Stage 2 Meaningful Use, requiring EHR solutions have the capabilities that clients need to meet their attestation goals and clinical measures.

Intuitive operation, improved billing capabilities and specialty-specific clinical content makes Allscripts Professional the solution of choice for solo practitioners as well as mid-sized, multispecialty practices. Allscripts Professional EHR 13.0 has a number of important enhancements and features, including:

  • Meaningful Use Stage 2 Compliance: Allscripts Professional has achieved complete and modular ONC 2014 certification, confirming that Allscripts Professional has the capabilities required for current Meaningful Use Stage 1 criteria and future Stage 2 criteria.
  • Patient Portal Integration: Allscripts Professional can send and receive secure messages with patients through full patient portal integration. Allscripts Professional is integrated with FollowMyHealth™ and Intuit Patient Portals, enabling messaging between patients and providers. Integration with a full patient portal is required for meeting Meaningful Use Stage 2 standards.

In addition, Allscripts Professional 13.0 also includes enhancements to core EHR functionality which can help clients increase user efficiency and improve day-to-day use, including the following capabilities:

  • Bi-Directional Immunizations: Receive immunization data from state immunization registries that are capable of exchanging data with practices. 
  • Care Plans and Goals: Build care plans, set goals, track patient progress, and identify barriers through the core EHR solution.
  • InfoButton Technology: Context sensitive patient education and referential decision support are now available through InfoButton technology.

To complement Allscripts Professional EHR 13.0, and to help position practices to attain Meaningful Use, Allscripts offers multiple service options:

  • Remote Assessments are available for all stages of Meaningful Use: Stage one, year one; stage one, year two; and stage two.
  • Onsite Consultative Services are also available, including Meaningful Use Attestation Readiness Validation, which features a comprehensive assessment of a practice's needs for Meaningful Use readiness.

About Allscripts Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a  Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit  www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs